1	Paciente	paciente	NCCS000	C0030705	persona	0-8	729_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	9-11	729_QUEST_clinical_caseMIR	SENT1	-	-
3	72	72		-	-	12-14	729_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	15-19	729_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0001779_1	entidad_observable_1	20-22	729_QUEST_clinical_caseMIR	SENT1	-	-
6	edad	edad	NCFS000	C0001779_2	entidad_observable_2	23-27	729_QUEST_clinical_caseMIR	SENT1	-	-
7	que	que	PR0CN000	-	-	28-31	729_QUEST_clinical_caseMIR	SENT1	-	-
8	acude	acudir	VMIP3S0	-	-	32-37	729_QUEST_clinical_caseMIR	SENT1	-	-
9	a	a	SPS00	-	-	38-39	729_QUEST_clinical_caseMIR	SENT1	-	-
10	urgencias	urgencia	NCFP000	C0439609	calificador	40-49	729_QUEST_clinical_caseMIR	SENT1	-	-
11	por	por	SPS00	C0678226	atributo	50-53	729_QUEST_clinical_caseMIR	SENT1	-	-
12	presentar	presentar	VMN0000	-	-	54-63	729_QUEST_clinical_caseMIR	SENT1	-	-
13	aparatoso	aparatoso	AQ0MS0	-	-	64-73	729_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	e	y	CC	C1706368	calificador	74-75	729_QUEST_clinical_caseMIR	SENT1	-	-
15	importante	importante	AQ0CS0	-	-	76-86	729_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
16	angioedema	angioedema	NCMS000	C0002994	trastorno	87-97	729_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
17	lingual	lingual	AQ0CS0	C2349948	calificador	98-105	729_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
18	.	.	Fp	-	-	105-106	729_QUEST_clinical_caseMIR	SENT1	-	-

1	No	no	RN	C1298908	calificador	107-109	729_QUEST_clinical_caseMIR	SENT2	-	-
2	presenta	presentar	VMIP3S0	-	-	110-118	729_QUEST_clinical_caseMIR	SENT2	-	-
3	urticaria	urticaria	NCFS000	C0221232#C0042109_1	anomalía_morfológica#trastorno_1	119-128	729_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Negacion
4	asociada	asociar	VMP00SF	-	-	129-137	729_QUEST_clinical_caseMIR	SENT2	-	-
5	ni	ni	CC	-	-	138-140	729_QUEST_clinical_caseMIR	SENT2	-	-
6	refiere	referir	VMIP3S0	-	-	141-148	729_QUEST_clinical_caseMIR	SENT2	-	-
7	antecedentes	antecedente	NCMP000	C0332119_1	situación_1	149-161	729_QUEST_clinical_caseMIR	SENT2	-	-
8	de	de	SPS00	C0332119_2	situación_2	162-164	729_QUEST_clinical_caseMIR	SENT2	-	-
9	alergia	alergia	NCFS000	C0020517	trastorno	165-172	729_QUEST_clinical_caseMIR	SENT2	B-Alergia	Negacion
10	a	a	SPS00	-	-	173-174	729_QUEST_clinical_caseMIR	SENT2	-	-
11	fármacos	fármaco	NCMP000	C0013227	sustancia	175-183	729_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
12	o	o	CC	-	-	184-185	729_QUEST_clinical_caseMIR	SENT2	-	-
13	alimentos	alimento	NCMP000	C0016452	sustancia	186-195	729_QUEST_clinical_caseMIR	SENT2	-	-
14	.	.	Fp	-	-	195-196	729_QUEST_clinical_caseMIR	SENT2	-	-

1	Entre	entre	SPS00	C0205103	calificador	197-202	729_QUEST_clinical_caseMIR	SENT3	-	-
2	sus	su	DP3CP0	-	-	203-206	729_QUEST_clinical_caseMIR	SENT3	-	-
3	antecedentes	antecedente	NCMP000	-	-	207-219	729_QUEST_clinical_caseMIR	SENT3	-	-
4	personales	personal	AQ0CP0	-	-	220-230	729_QUEST_clinical_caseMIR	SENT3	-	-
5	destacan	destacar	VMIP3P0	-	-	231-239	729_QUEST_clinical_caseMIR	SENT3	-	-
6	diabetes	diabetes	NCFN000	C0011860_1	trastorno_1	240-248	729_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
7	mellitus	mellitus	AQ0CN0	C0011860_2	trastorno_2	249-257	729_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
8	tipo	tipo	NCMS000	C0011860_3	trastorno_3	258-262	729_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
9	2	2	Z	C0011860_4	trastorno_4	263-264	729_QUEST_clinical_caseMIR	SENT3	I-Calificador	-
10	,	,	Fc	-	-	264-265	729_QUEST_clinical_caseMIR	SENT3	-	-
11	dislipemia	dislipemia	NCFS000	-	-	266-276	729_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
12	,	,	Fc	-	-	276-277	729_QUEST_clinical_caseMIR	SENT3	-	-
13	hipertensión	hipertensión	NCFS000	C0020538_1	trastorno_1	278-290	729_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
14	arterial	arterial	NC00SC0	C0020538_2	trastorno_2	291-299	729_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
15	,	,	Fc	-	-	299-300	729_QUEST_clinical_caseMIR	SENT3	-	-
16	hipotiroidismo	hipotiroidismo	NCMS000	C0020676	trastorno	301-315	729_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
17	y	y	CC	C1706368	calificador	316-317	729_QUEST_clinical_caseMIR	SENT3	-	-
18	enfermedad	enfermedad	NCFS000	C0030567_1	trastorno_1	318-328	729_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
19	de	de	SPS00	C0030567_2	trastorno_2	329-331	729_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
20	Parkinson	parkinson	NC00KE0	C0030567_3	trastorno_3	332-341	729_QUEST_clinical_caseMIR	SENT3	I-Grp_Enfermedad	-
21	.	.	Fp	-	-	341-342	729_QUEST_clinical_caseMIR	SENT3	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	343-345	729_QUEST_clinical_caseMIR	SENT4	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	346-357	729_QUEST_clinical_caseMIR	SENT4	-	-
3	habitual	habitual	AQ0CS0	C0205353	calificador	358-366	729_QUEST_clinical_caseMIR	SENT4	-	-
4	con	con	SPS00	C0332287	atributo	367-370	729_QUEST_clinical_caseMIR	SENT4	-	-
5	metformina	metformina	NC00SC0	C0025598	producto#sustancia	371-381	729_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
6	,	,	Fc	-	-	381-382	729_QUEST_clinical_caseMIR	SENT4	-	-
7	simvastatina	simvastatina	NC00SC0	C0074554	producto#sustancia	383-395	729_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
8	,	,	Fc	-	-	395-396	729_QUEST_clinical_caseMIR	SENT4	-	-
9	enalapril	enalapril	NC00SC0	C0014025	sustancia	397-406	729_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
10	,	,	Fc	-	-	406-407	729_QUEST_clinical_caseMIR	SENT4	-	-
11	tiroxina	tiroxina	NCFS000	C0040165	sustancia	408-416	729_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
12	y	y	CC	C1706368	calificador	417-418	729_QUEST_clinical_caseMIR	SENT4	-	-
13	levodopa	levodopa	NC00SC0	C0023570	sustancia	419-427	729_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
14	.	.	Fp	-	-	427-428	729_QUEST_clinical_caseMIR	SENT4	-	-

1	¿	¿	Fia	-	-	429-430	729_QUEST_clinical_caseMIR	SENT5	-	-
2	Cuál	cuál	PT0CS000	-	-	430-434	729_QUEST_clinical_caseMIR	SENT5	-	-
3	de	de	SPS00	C0332285	atributo	435-437	729_QUEST_clinical_caseMIR	SENT5	-	-
4	los	el	DA0MP0	-	-	438-441	729_QUEST_clinical_caseMIR	SENT5	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	442-452	729_QUEST_clinical_caseMIR	SENT5	-	-
6	fármacos	fármaco	NCMP000	C0013227	sustancia	453-461	729_QUEST_clinical_caseMIR	SENT5	-	-
7	es	ser	VSIP3S0	-	-	462-464	729_QUEST_clinical_caseMIR	SENT5	-	-
8	con	con	SPS00	C0332287	atributo	465-468	729_QUEST_clinical_caseMIR	SENT5	-	-
9	mayor	mayor	AQ0CS0	C0205164#C1704243#C0549177	calificador	469-474	729_QUEST_clinical_caseMIR	SENT5	-	-
10	probabilidad	probabilidad	NCFS000	-	-	475-487	729_QUEST_clinical_caseMIR	SENT5	-	-
11	el	el	DA0MS0	-	-	488-490	729_QUEST_clinical_caseMIR	SENT5	-	-
12	fármaco	fármaco	NCMS000	C0013227	sustancia	491-498	729_QUEST_clinical_caseMIR	SENT5	-	-
13	causal	causal	AQ0CS0	-	-	499-505	729_QUEST_clinical_caseMIR	SENT5	-	-
14	del	del	SP+DA	-	-	506-509	729_QUEST_clinical_caseMIR	SENT5	-	-
15	cuadro	cuadro	NCMS000	-	-	510-516	729_QUEST_clinical_caseMIR	SENT5	-	-
16	clínico	clínico	AQ0MS0	C0205210	calificador	517-524	729_QUEST_clinical_caseMIR	SENT5	-	-
17	descrito	describir	VMP00SM	-	-	525-533	729_QUEST_clinical_caseMIR	SENT5	-	-
18	?	?	Fit	-	-	533-534	729_QUEST_clinical_caseMIR	SENT5	-	-
19	:	:	Fd	-	-	534-535	729_QUEST_clinical_caseMIR	SENT5	-	-
20	.	.	Fp	-	-	535-536	729_QUEST_clinical_caseMIR	SENT5	-	-

